Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Ovarian Cancer Metastatic × aldesleukin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 4 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Neoplasms 1 Ovarian Cancer Metastatic 1 Neoplasms 1 Multiple Myeloma 1 Metastatic HPV-16 Positive Squamous Cell Anal Cancer 1 Metastatic Bladder Urothelial Carcinoma 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Duodenal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Adenocarcinoma of Lung 1

Interventions

fludarabine 1 aldesleukin 1 Interleukin-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389229 2020-12-16

OVSTAR

Immetacyte Ltd

Phase 1/2 Withdrawn

Ovarian Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡